WebCingulate currently has two (2) product candidates, CTX-1301 and CTX-1302, that are being developed to serve the approximate $18 billion annual U.S. ADHD market. A third product candidate, CTX-2103, is being developed to serve the roughly $5 billion U.S. … 23 Feb 2024 Cingulate Announces Positive Top-Line Results from Fed/Fast Study … Pipeline Overview. Cingulate® completed a proof-of-concept trial in human subjects … Cingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 … Shane J. Schaffer, PharmD is a Co-Founder of Cingulate Therapeutics and … About Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage … Mr. Gallagher is a Co-Founder of Cingulate Therapeutics and serves as a member … WebCingulate Inc. 1,061 followers. 2mo. Today we announce our Q3 2024 financial results and provided a clinical and business update, including updated study timelines for our lead candidate, CTx-1301 ...
CING - Cingulate Inc. Stock Price and Quote - FINVIZ.com
WebApr 6, 2024 · Cingulate's stock was trading at $1.00 at the beginning of the year. Since then, CING stock has decreased by 3.8% and is now trading at $0.9619. View the best … WebMar 14, 2024 · Cingulate Inc. (CING) full year performance was 10.92%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cingulate Inc. shares are logging -40.00% during the 52-week period from high price, and 98.80% higher than the ... panza chelera
CING - Cingulate Stock Price - Barchart.com
WebApr 6, 2024 · How much insider selling is happening at Cingulate? Insiders have sold a total of 17,532 Cingulate shares in the last 24 months for a total of $22,265.64 sold. This page (NASDAQ:CING) was last updated on 4/8/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Webcingulum. ( ˈsɪŋɡjʊləm) n, pl -la ( -lə) (Anatomy) anatomy a girdle-like part, such as the ridge round the base of a tooth or the band of fibres connecting parts of the cerebrum. [C19: … WebApr 12, 2024 · Analysts like Cingulate more than other Medical companies. The consensus rating score for Cingulate is 3.00 while the average consensus rating score for medical companies is 2.65. Learn more on how CING compares to other companies. What analysts cover Cingulate? オーバーラップ 溶接 意味